DC Circuit Orders Supplemental Briefing in Federal

New Post Public Reply Private Reply Replies (0) Message Board
CherylShuman

DC Circuit Orders Supplemental Briefing in Federal Landmark Medical Marijuana Case

October 17th, 2012 
Posted by Joe Elford

Just hours after the U.S. Court of Appeal for the D.C. Circuit heard  oral arguments in the federal landmark case  Americans for Safe Access v. Drug Enforcement Administration the court ordered supplemental briefing on the issue of “standing.” In a rare move for a case that has been covered by the Associated Press Reuters CNN Bloomberg News Los Angeles Times San Francisco Chronicle Huffington Post , and others, the request for additional briefing indicates that the court is taking the issue of medical marijuana very seriously.

Yesterday’s  order asks the petitioners to provide the court with details about how plaintiff Michael Krawitz, a U.S. Air Force veteran, sustained harm as a result of the federal government’s refusal to recognize the therapeutic value of marijuana. During yesterday’s oral arguments, Americans for Safe Access (ASA) Chief Counsel Joe Elford argued that Krawitz had been denied medical services and treatment from Veterans Administration physicians because of his status as a medical marijuana patient.

Specifically, the court ordered ASA to file a brief not to exceed five pages in order to “clarify and amplify the assertions made [by] Michael Krawitz regarding his individual standing,” and “more fully explain precisely the nature of the injury that gives him standing.” The brief is due by Monday.

If ASA can reasonably show that Krawitz has been harmed by a federal policy that holds marijuana has no medical value, the country’s largest medical marijuana advocacy group may also get the court to rule on the merits of the case — whether the scientific evidence of medical efficacy is ample enough to reclassify marijuana from its current status as a Schedule I substance.

We remain hopeful that the science on medical marijuana will prevail over politics in order to overcome the decades-long effort by the federal government to keep marijuana out of the reach of millions of Americans who would benefit from its use.

ShareThis

10 Responses to “DC Circuit Orders Supplemental Briefing in Federal Landmark Medical Marijuana Case”

  1. Delightful Dabber Says: 

    Great job guys. I feel this would be a great time to bring up the federal government’s own medical pot program in Mississippi. The law and this federal program contradict. I feel the brief should have at least one sentence devoted to this matter.

  2. Mel mower Says: 

    SCIENCE OVER POLITICS! BAM

  3. jeanna prell Says: 

    This seems ominous to me. It seems they are demanding proof that, in their minds cannot be proved, ie a Vet who claims discrimination, but can’t be verified because of the rules. Look out for Catch 22, the Government(Corporate Lawyers) are excellent at this type of deception.

  4. Joe Says: 

    After the votes that come in on the 7th showing overwhelming support for anything to do with medical marijuana or even full llegalization in most states maybe they will start to understand.

  5. Charles Strout Says: 

    The DEA argues that medical marijuana is a drug of abuse. But the same is true for tobacco, alcohol, legal pharmaceutical shelved, and non-shelved drugs listed as Schedule 2 so they can be utilized in treatment by physicians as required. The DEA’s concern to override the legitimate need of millions of suffering patients for relief of their medical symptoms that marijuana can provide, described throughly in their own US Fed Gov’t Patent #6630507 is completelly specious, and without any validation of evidence. Millions of suffering medical patients are legally effectively benefiting therapeutically utilizing medical marijuana as their medicine. It appears the arguments of the DEA would rather prescribe a jail cell, and refer to those suffering patients as criminals, and prisoners instead, benefiting absoutely nobody, except the profiteers of the power structure, and the Big-Pharmaceutical Companies.

  6. claygooding Says: 

    Wouldn’t the 3000 year old Chinese medical scrolls give historical proof of medical applications and couldn’t the plaintiff use Judge Young’s ruling as a useful tool for proof of the DEA’s arbitrary refusal to re-schedule marijuana since 1988?

  7. ron Says: 

    How about the US Government patent on Cannabinoids? I would think this can be use in this case.

    Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants.

  8. Correct Me If I'm Wrong Says: 

    I’m re-posting this from an earlier story…glad to hear that this may actually be getting fair consideration. I just want to make sure I understand exactly what this means…I can be rather dense sometimes <img src= " /> This case is an “appeal” to have the courts force the DEA to take another look at their classifying MMJ in Schedule I, right? Does this mean that the DEA can simply find another way (i.e. word differently) yet another rejection? What exactly can these 3 judges do, in terms of actual, measurable change? It concerned me a bit when one of the judges asked whether or not THEY needed to listen to the “agency”…citing the fact that they were scientists and the judges were not. Help me out here. Where can a favorable ruling actually go??

  9. Rick Steeb Says: 

    In order to have “standing” we must describe the nature of our injury– How about starting with the constant low-grade terror that comes with the knowledge that the feds can legally come and take us away? How about the atrocities perpetrated against our providers? The black market prices of our medicine? The denial of “Equal Protection” with Elvy and Irvin?

    I have to commit a “federal crime” to maintain my intraoccular pressures at safe levels, even with my use of two prescription eye drops. That adds insult to injury. That is utterly unacceptable.

  10. claygooding Says: 

    Rick,please add the terror of being locked up in a jail,where medical treatment is non-existent for inmates.

    Example:

    Wash. inmate with dairy allergy dies after eating oatmeal

    http://www.katu.com/news/local/174446621.html

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 7

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 8

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 8

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 7

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 5

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 8

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 7

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading

Top 5 Most Recently Viewed Articles

Duke Robotics Expands Presence with New Subsidiary in Greece

Updated Category News Views 118

Duke Robotics Strengthens Market Position with New Greek Subsidiary Duke Robotics Corp. (OTCQB:DUKR) has recently taken a significant step to amplify its presence in the civilian market by establishing Duke Robotics Hellas I.K.E. in Greece. This strategic move is poised to broaden the Company's operational landscape and enhance its capabilities to cater to emerging...

Continue Reading
Transforming Global Payments: How TransFi's BizPay Innovates Business Transactions

Updated Category News Views 272

TransFi's BizPay: A Game Changer in Global Payments TransFi has introduced BizPay, a cutting-edge payment platform designed for swift, compliant cross-border transactions utilizing AI-powered technology. In today's dynamic financial landscape, navigating global payments can often feel daunting due to differing time zones, various banking systems, and complex regulations....

Continue Reading
MicroTech Awarded Major Contract in Federal Print Services

Updated Category News Views 267

MicroTech Secures Significant Contract with Government Agency MicroTech, a prominent player in innovative IT solutions, has recently announced a major achievement, securing a contract from the Government Printing Office (GPO) that falls under the noteworthy D951-M program. This contract allows MicroTech to provide comprehensive managed print services, which encompass...

Continue Reading
MemryX's MX4 Roadmap: Pioneering Efficient AI Data Centers

Updated Category News Views 142

MemryX Introduces the MX4 Roadmap MemryX Inc., a company dedicated to accelerating production AI inference, has unveiled its strategic roadmap for the MX4. This next-generation accelerator aims to extend the company’s unique "at-memory" dataflow architecture from edge applications into larger data center environments. By leveraging advanced 3D hybrid-bonded memory,...

Continue Reading
Microsoft's Dividend Boost and Buyback Strategy Leads to Growth

Updated Category News Views 110

Microsoft's Strategic Financial Moves Recently, Microsoft Corporation (NASDAQ: MSFT) made waves by announcing a significant increase in its quarterly dividend and a new share repurchase program. Following the news, Deutsche Bank reaffirmed its Buy rating on Microsoft’s stock and set a price target of $475. This move to raise the dividend by 10.7%, from $0.75 to $0.83...

Continue Reading